Torcetrapib and Atorvastatin — Should Marketing Drive the Research Agenda?
J. Avorn
- 23 Jun, 2005
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
